IL6 and cancer: Serum IL-6 level-based cancer prognosis in the Multi-Ethnic Cohort Study revealed association with significantly poor survival in AAs (Hazard ratio: 2.71) compared to CAs (Hazard ratio: 1.71) [154,155].